Filing Flows › Comparisons › PGNY vs SHC
Progyny vs Sotera Health: PGNY and SHC compared
Progyny is the larger company: $341M of revenue in its latest quarter (Q3 2026) against $325M for Sotera Health (Q3 2026). Progyny is growing faster (+9% against +4% a year earlier). Sotera Health is more profitable, with an operating margin of 25.8% against 10.3%.
Where the money goes: PGNY and SHC
Progyny (PGNY) · Q3 2026
Progyny, Q3 2026: revenue $341M (+9% year over year), operating margin 10.3%, net earnings $26.3M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
Sotera Health (SHC) · Q3 2026
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.
| Progyny (PGNY) | Sotera Health (SHC) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $341M | $325M |
| Revenue growth, Y/Y | +9% | +4% |
| Gross margin | 24.5% | 55.6% |
| Operating margin | 10.3% | 25.8% |
| Net earnings | $26.3M | $58.4M |
| Net margin | 7.7% | 18.0% |
| Operating cash flow | $56.6M | $111M |
| Free cash flow | $47.2M | $57.7M |
| Market value | $2.8B | $5.2B |
| P/E | 31.1× | 30.2× |
| Analysts’ mean target | $34.83 | $21.94 |
Where the revenue comes from
Progyny
- Fertility benefits services revenue: $223M (65%)
- Pharmacy benefits services revenue: $118M (35%)
Sotera Health
- Sterigenics: $209M (64%)
- Nelson Labs: $60.6M (19%)
- Nordion: $55.0M (17%)
Questions
Which is bigger, Progyny or Sotera Health?
Progyny is the larger company: $341M of revenue in its latest quarter (Q3 2026) against $325M for Sotera Health (Q3 2026).
Is Progyny or Sotera Health growing faster?
Progyny is growing faster (+9% against +4% a year earlier).
Which is more profitable, Progyny or Sotera Health?
Sotera Health is more profitable, with an operating margin of 25.8% against 10.3%.
More: Progyny earnings · how Progyny makes money · Sotera Health earnings · how Sotera Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.